Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Zosano Pharma Corporation (ZSAN) stock profile

Zosano Pharma Corporation is a biopharmaceutical enterprise, currently in the clinical development phase, focused on supplying therapeutic agents and other biologically active substances to patients afflicted with migraine using its specialized transdermal microneedle system. Their leading experimental compound, Qtrypta (M207), represents a distinct formulation of zolmitriptan, specifically intended for the swift management of acute migraine episodes. The company commenced operations in 2006 and maintains its principal offices in Fremont, California. Notably, Zosano Pharma Corporation initiated a voluntary Chapter 11 reorganization petition with the U.S. Bankruptcy Court for the District of Delaware on June 1, 2022.

Key facts

SymbolZSAN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CEOSteven Lo
Employees40
HeadquartersFremont, CA, US
IPO2015-01-27
Websitewww.zosanopharma.com

Explore ZSAN on Vantafin

  • Zosano Pharma Corporation Overview
  • Zosano Pharma Corporation Financials
  • Zosano Pharma Corporation Events
  • Zosano Pharma Corporation SEC filings
  • Zosano Pharma Corporation Insider transactions
  • Zosano Pharma Corporation Transcripts

Frequently asked questions

What does Zosano Pharma Corporation (ZSAN) do?
Zosano Pharma Corporation is a biopharmaceutical enterprise, currently in the clinical development phase, focused on supplying therapeutic agents and other biologically active substances to patients afflicted with migraine using its specialized transdermal microneedle system. Their leading experimental compound, Qtrypta (M207), represents a distinct formulation of zolmitriptan, specifically intended for the swift management of acute migraine episodes. The company commenced operations in 2006 and maintains its principal offices in Fremont, California. Notably, Zosano Pharma Corporation initiated a voluntary Chapter 11 reorganization petition with the U.S. Bankruptcy Court for the District of Delaware on June 1, 2022.
Where is ZSAN stock listed?
Zosano Pharma Corporation trades under the ticker ZSAN on NASDAQ.
How can I research ZSAN's financials and filings?
Vantafin provides Zosano Pharma Corporation's income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the ZSAN profile.